Page last updated: 2024-09-05

top 53 and Experimental Neoplasms

top 53 has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyagi, K; Kobunai, T; Oh-hara, T; Shibata, J; Sugimoto, Y; Terada, T; Tsuruo, T; Utsugi, T; Wierzba, K; Yamada, Y1
Asai, T; Baba, K; Irimura, K; Oku, N; Shimizu, K; Takada, M1

Other Studies

2 other study(ies) available for top 53 and Experimental Neoplasms

ArticleYear
Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Cancer research, 1996, Jun-15, Volume: 56, Issue:12

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; DNA, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasms, Experimental; Specific Pathogen-Free Organisms; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1996
Potential usage of liposomal 4beta-aminoalkyl-4'-O-demethyl-4-desoxypodophyllotoxin (TOP-53) for cancer chemotherapy.
    Biological & pharmaceutical bulletin, 2002, Volume: 25, Issue:6

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Blood Vessels; Body Weight; Enzyme Inhibitors; Etoposide; Liposomes; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Survival Analysis; Topoisomerase II Inhibitors

2002